Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Zolpidem CR and Hospitalized Patients With DementiaCompleted
NCT00814502NAUpdated May 22, 2017
Sponsor: Massachusetts General Hospital
Dementia · Alzheimer Disease · Dementia, Vascular · Sleep Disorders
United States
Which Therapy for Acute Heart Attacks? (The WEST Study)Completed
NCT00121446Phase 2, Phase 3Updated May 19, 2017
Sponsor: University of Alberta
Myocardial Infarction
Canada
Control of Epidemic Influenza Through a School-based Influenza Vaccination ProgramCompleted
NCT00138294Phase 4Updated May 19, 2017
Sponsor: Baylor College of Medicine
Influenza
United States
Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)Withdrawn
NCT01757574Phase 4Updated May 18, 2017
Sponsor: Johns Hopkins University
Chronic Inflammatory Demyelinating Neuropathy
United States
Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLCTerminated
NCT00801801Phase 2Updated May 17, 2017
Sponsor: Francisco Robert,MD
Non Squamous Cell Lung Cancer · Non Small Cell Lung Cancer
United States
An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal CancerCompleted
NCT01339832N/AUpdated May 17, 2017
Sponsor: Hoffmann-La Roche
Colorectal Cancer
Switzerland
A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens AloneCompleted
NCT01288573Phase 1, Phase 2Updated May 16, 2017
Sponsor: Genzyme, a Sanofi Company
Ewing's Sarcoma/Soft Tissue Sarcoma · Neuroblastoma · Brain Tumors
Belgium, Czechia, Denmark, France, Germany +7 more
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of AlemtuzumabCompleted
NCT00930553Phase 3Updated May 15, 2017
Sponsor: Genzyme, a Sanofi Company
Multiple Sclerosis, Relapsing-Remitting
United States, Argentina, Australia, Austria, Belgium +18 more
First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid TumorCompleted
NCT01156870Phase 1Updated May 10, 2017
Sponsor: Sanofi
Neoplasm Malignant
United States, France, Spain
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesCompleted
NCT02058160Phase 3Updated May 9, 2017
Sponsor: Sanofi
Type 2 Diabetes
United States, Australia, Canada, Chile, Czechia +13 more
Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DMCompleted
NCT02058147Phase 3Updated May 9, 2017
Sponsor: Sanofi
Type 2 Diabetes
United States, Australia, Belgium, Canada, Chile +18 more
Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver MetastasesWithdrawn
NCT01646554Phase 2, Phase 3Updated May 9, 2017
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Colorectal Cancer Metastatic · Liver Metastases · KRAS Mutated Colorectal Cancer
Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot StudyCompleted
NCT01038011Phase 2Updated May 8, 2017
Sponsor: University of Zurich
Ankylosing Spondylitis
Switzerland
Effect of Bile Acid Secretion and Sequestration on GLP-1 SecretionCompleted
NCT02445508NAUpdated May 3, 2017
Sponsor: University Hospital, Gentofte, Copenhagen
Diabetes Mellitus, Type 2
Denmark
Efficacy of a Chronic Care Model Supported by Self Monitoring of Blood Glucose With BGStar Over Usual Care in Improving Glycemic Control in Patients With Type 2 Diabetes Not Treated With InsulinCompleted
NCT02082028NAUpdated May 3, 2017
Sponsor: Sanofi
Diabetes Mellitus
Italy
Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of VandetanibCompleted
NCT01539655Phase 1Updated May 2, 2017
Sponsor: Sanofi
Medullary Thyroid Cancer
United States
Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-CholesterolCompleted
NCT01959971Phase 1Updated May 2, 2017
Sponsor: Sanofi
Hypercholesterolemia
United States
CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical PracticeCompleted
NCT02109250N/AUpdated May 2, 2017
Sponsor: Genzyme, a Sanofi Company
Metastatic Medullary Thyroid Cancer
Belgium
DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed InfantsCompleted
NCT02094833Phase 3Updated Apr 26, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Diphtheria · Tetanus · Pertussis · Haemophilus Influenzae Type b Infection
South Korea
Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis RegimenCompleted
NCT01930357Phase 2Updated Apr 25, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Rabies
Philippines
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy PatientsCompleted
NCT00186940N/AUpdated Apr 25, 2017
Sponsor: St. Jude Children's Research Hospital
Leukemia · Lymphoma · Tumor Lysis Syndrome · Hyperuricemia
United States
Donor Enhancement With Plerixafor Post Myeloablative Allogeneic TransplantCompleted
NCT01280955Phase 1, Phase 2Updated Apr 25, 2017
Sponsor: Mitchell Horwitz, MD
Failure of Bone Marrow Graft
United States
Assessing the Determinants of 6-minute Walk Test and Its Correlation With Quality of LifeCompleted
NCT03123757NAUpdated Apr 21, 2017
Sponsor: Precision Health Economics
Aged
Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous LeukemiaWithdrawn
NCT02520102Phase 2Updated Apr 20, 2017
Sponsor: Sanofi
Acute Myeloid Leukemia NOS
A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza VaccineCompleted
NCT01665807Phase 4Updated Apr 19, 2017
Sponsor: Brenda Coleman
Influenza · Vaccination Site Reactions (HT)
Canada

Previous page Next page